ClenMed 40 mcg MediPharma

Description

ClenMed 40 mcg MediPharma — Backed by a rigorous commitment to quality, this pharmaceutical-grade thermogenic compound accelerates fat metabolism and supports lean body composition during cutting phases. Enhances metabolic rate while preserving lean muscle tissue. This formulation is dosed at 40 mcg per unit.

Key Benefits

• Beta-2 agonist — raises basal metabolic rate and lipolysis
• 2-on / 2-off protocol to prevent beta-receptor downregulation
• Titrate slowly — tremors and tachycardia above 80 mcg/day
• Supplement taurine 3–5 g/day and potassium
• Supporting compound — diet deficit does 90% of the work
• Each unit dosed at 40 mcg — see Recommended Dosage below for protocol-specific intake

How It Works

Selective beta-2 adrenergic agonist. Raises basal metabolic rate, promotes lipolysis, mildly anti-catabolic. Increases body temperature and heart rate. Tissue specificity favours fat over muscle at therapeutic doses.

Pharmacokinetics

Plasma half-life approximately 26–36 hours. Daily dosing. Steady-state in 4–5 days. Receptor downregulation develops after 2 weeks of continuous use — hence cycling.

Potential Side Effects

Tremors, tachycardia, cramps (taurine deficit), insomnia, sweating. Tachycardia persistent above 100 bpm — drop dose. Cardiac hypertrophy risk on long runs. Not for cardiovascular-compromised users.

Cycle & Stacking Guide

2-on / 2-off cycling typical, up to 6–8 weeks total within a cutting phase. Stacks with T3 (aggressive) or with fat-loss AAS protocol (test + var + clen). Always with taurine 3–5 g/day and potassium/magnesium supplementation.

Manufacturer Notes

MediPharma produces to a standard European formulary pattern. Vial specs and carrier details are printed on every label.

Storage & Handling

Store at recommended temperature (15–25°C; peptides and HGH at 2–8°C after reconstitution). Protect from light and moisture. Keep out of reach of children. For research and educational purposes only.